- Highlighted Item:
- Publication Date:
- Publication Type:Presentation
- Scientific Area:
- Industry Type:
2. Risk assessment of potential mutagenic impurities in anti-hypertensive drug products approved in Brazil - Fernanda Waechter (Slides)
This presentation was given by Lhasa Limited, Principal Application Scientist, Fernanda Waechter, as part of the webinar 'An industry perspective on the qualification of impurities and degradation products to meet RDC 53, ICH M7, Q3A and Q3B guidelines.'
This publication is a PDF copy of the slides presented.